Effect of 0.15% sodium hyaluronate on tear film breakup time in healthy anesthetized cats

Vet Ophthalmol. 2023 Jan;26(1):46-52. doi: 10.1111/vop.13030. Epub 2022 Oct 13.

Abstract

Objectives: This study aimed to evaluate the effect of 0.15% sodium hyaluronate (SH) on tear film breakup time (TFBT) in healthy anesthetized cats.

Procedures: Forty cats undergoing elective surgery were enrolled. TFBT was assessed before anesthesia to obtain baseline values. As a preanesthetic medication, cats received midazolam, tramadol, and cetamine combined in the same syringe. For anesthetic induction and maintenance, propofol and isoflurane were used. After a 15 min stabilization period to achieve the surgical anesthetic plane, one eye was treated with one drop of SH, while the other eye received saline and served as a control. TFBT was measured at the end of the general anesthesia (T40) and 35 (T75) and 80 min (T120) after the termination of the anesthesia. TFBT values were compared between the control and SH-treated eyes; both values were also compared with the baseline values (p < .05).

Results: In the control eyes, TFBT significantly decreased from baseline at all time points (p < .001), while in SH-treated eyes, TFBT significantly increased from baseline only at T40 (p < .0001). In SH-treated eyes, TFBT was significantly higher than that in the control eyes at all time points (p < .001).

Conclusions: In healthy cats, TFBT decreases significantly after 40 min of general anesthesia, and one drop of 0.15% sodium hyaluronate was able to maintain the stability of the tear film for up to 75 min in treated eyes. However, the isolated effect of each drug used in our anesthetic protocol on TFBT should be executed in further studies.

Keywords: anesthesia; feline; ophthalmic lubricant; qualitative tear deficiency; tear film breakup time; tear stability.

MeSH terms

  • Animals
  • Cat Diseases* / drug therapy
  • Cats
  • Dry Eye Syndromes* / drug therapy
  • Dry Eye Syndromes* / veterinary
  • Eye
  • Hyaluronic Acid / pharmacology
  • Hyaluronic Acid / therapeutic use
  • Ophthalmic Solutions / therapeutic use
  • Tears

Substances

  • Hyaluronic Acid
  • Ophthalmic Solutions